Another study reported a rate of pathogenic germline mutations in MUTYH, ATM, BRCA1, BRCA2 and BRIP1 of 7.2% in patients with high-risk, very high risk or metastatic PC (29). The gene discussed is BRCA1; the disease is pachyonychia congenita.